Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.

US regulators approved Moderna Inc.’s Covid vaccine for children, but for a narrower group than before, continuing Robert F.

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...

Moderna, Inc. (MRNA) on Thursday announced that the U.S. Food and Drug Administration (FDA) has fully approved its COVID-19 ...

Moderna announced Monday that its COVID-19 vaccine booster increases antibody levels against the omicron variant within a month of getting the shot.. In a lab study, the company gave 20 fully ...

Moderna’s Covid-19 vaccine is safe and generated an immune response in children ages 6 months through 17 years that’s comparable to the response in adults, according to documents posted by the ...

Moderna asked U.S. regulators Thursday to authorize its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially making shots available for millions of kids by summer.

Moderna's candidate COVID-19 vaccine is even more effective than Pfizer's, trial results show, a "light at the end of the tunnel" for the pandemic.

Moderna Inc. said its COVID-19 vaccine remained 93% effective six months after the second shot as it reported second-quarter earnings and revenue that beat expectations.

Moderna early data shows coronavirus vaccine is nearly 95% effective 03:57. For the second time this month, there's promising news from a COVID-19 vaccine candidate.